Bruker (BRKR) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts BRKR Hot Sheet
Price: $57.70 -0.4%
Financial Fact:
Cost of product revenue: 172.2M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Cost of product revenue: 172.2M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Bruker (NASDAQ: BRKR) reported Q2 EPS of $0.20, in-line with the analyst estimate of $0.20. Revenue for the quarter came in at $371.7 million versus the consensus estimate of $410.39 million.
GUIDANCE:
Bruker sees FY2016 EPS of $0.97-$1.02, versus the consensus of $1.01.
For earnings history and earnings-related data on Bruker (BRKR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
